IO Frontiers World 2019

15 Top Biotechs to Watch in 2018


The pace of innovation across immuno-oncology biotechs is gaining speed and it can be challenging to keep track of scientific developments, new technologies and who’s looking for their next big partnership.

So, we’re keeping tabs on the innovators and disruptors for you…

The annual ‘Top Biotechs to Watch’ e-book examines 15 of the world’s leading immuno-oncology biotechnology companies, providing you with an at-a-glance view plus more detailed information on how their pipelines are developing.

Do you think anyone has been overlooked?

You can download the ebook below.

As an anti-spam measure, please type the characters you see in the image (case sensitive).


  • "Great venue to solidify and harmonize on the current challenges facing this sector - in real time. The caliber of the speakers and session contents was premier. “
    Dolores Baksh
    Innovation Leader, GE Healthcare
  • “A great event to learn about the hurdles that are needed to be overcome to get through the clinic.”
    Devin Bridgen
    Scientist, strategic partnerships, SQZ Biotech
  • "It was a great opportunity to share current data and thinking about the development of therapeutics directed at modulating the immune response to cancer."
    Lance Leopold
    Vice President, Head of Oncology Development, Incyte Corporation
  • "Phacilitate provides a unique forum, bringing together research, process development, and commercial leaders on the cutting edge of cell, gene, and immunotherapy. A great conference for anyone wanting a comprehensive view of the field."
    Dr James Trager
    Vice President, Research & Product Development, Dendreon
  • “In the rapidly moving Advanced Therapy market, Phacilitate remains one of the premier events.”
    David James
    CEO, Scinogy